Ted Randolph is a Co-Founder of VitriVax. Ted is the Gillespie Professor in the Department of Chemical and Biological Engineering and Co-Director for the Center for Pharmaceutical Biotechnology at the University of Colorado, Boulder. Ted is a recognized world leader in protein stabilization and lyophilization technology in processes for enzymatic catalysis, particle formation, and drug delivery, with decades of experience in biomolecule formulation and vaccine development. His research focuses primarily on the stabilization and delivery of protein-based therapeutics and vaccines. Ted received his BS in Chemical Engineering from the University of Colorado, Boulder and his Ph.D. in Chemical Engineering from the University of California, Berkeley.